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ABSTRACT
The objective of the current study was to evaluate
the dynamics of infection and the immunological re-
sponse to varying numbers of Escherichia coli injected
into the mammary glands of primiparous cows during
the periparturient period. Primiparous cows have been
shown to be more resistant to intramammary E. coli
challenge, and an increase of the inoculum dose by 2
log10 units induced a more rapid clinical response and
clearance of the organisms. Recognition of lipopolysac-
charide (LPS) is a key event in the innate immunity
response to gram-negative infection and is mediated by
the accessory molecules CD14 and LPS-binding protein
(LBP). Primiparous cows were inoculated with 1 × 104
(Group A; n = 8) or 1 × 106 (Group B; n = 8) cfu E. coli
P4:O32 in their 2 left quarters during the peripartur-
ient period. Clinical examination and analysis of blood
and milk parameters, including IL-8, complement frag-
ment 5a (C5a), LBP, and soluble CD14 (sCD14), were
performed from d −4 to d +3 relative to infection. Pri-
miparous cows in Group B initiated a more rapid clini-
cal response following intramammary infection (IMI),
resulting in typical clinical signs and changes in blood
and milk parameters approximately 3 h earlier com-
pared with primiparous cows in Group A. Based on
average milk production in the noninfected quarters on
d +2 postinoculation, all heifers reacted as moderate
responders. Distinct differences in the kinetic patterns
of rectal temperature, somatic cell count (SCC), IL-8,
C5a, LBP, and sCD14 were observed between both
groups during the early phase of inflammation. Both
C5a and IL-8 increased before cellular influx into the
infected glands, followed by increases in sCD14 and
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LBP. In conclusion, primiparous cows are able to clear
an intramammary E. coli infection efficiently. More-
over, increasing the inoculumdose induces amore rapid
inflammatory reaction, mainly because of early activa-
tion of the innate host immune response.
(Key words: primiparous dairy cow, Escherichia coli,
mastitis, inoculum size)
Abbreviation key: BLC = blood leukocyte count,
C5a = complement fragment 5a, LBP = LPS-binding
protein,mCD14 = membrane-associated CD14, PIH =
postinfusion hour, PMN = polymorphonuclear neutro-
phil, sCD14 = soluble CD14, TLR = Toll-like receptor,
QMP = quarter milk production.
INTRODUCTION
The importance of innate immunity in recognizing
microbial pathogens and mounting a response against
them is now widely recognized. The immediate, innate
immune response is mediated largely by white blood
cells, such as polymorphonuclear neutrophils (PMN)
and macrophages, cells that phagocytose and kill the
pathogens and concurrently coordinate additional host
responses by synthesizing awide range of inflammatory
mediators and cytokines (Aderem and Ulevitch, 2000).
Several species of gram-negative bacteria, including
Escherichia coli, Klebsiella pneumoniae, and various
species ofEnterobacter, are commonmastitis pathogens
and are all characterized by the presence of endotoxin
or LPS in their outer membrane. Lipopolysaccharide
is a proinflammatory molecule that is shed from the
bacterial surface during bacterial replication or death
(Burvenich et al., 2003). Clinical signs following experi-
mentally induced E. colimastitis contributed to media-
tor shock, rather than to endotoxin shock, because endo-
toxin mainly plays a local role (Hoeben et al., 2000;
Dosogne et al., 2002).
Several of the proinflammatory cytokines that medi-
ate the localized and systemic response to gram-nega-
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tive mastitis, including IL-1β, IL-6, IL-8, and TNF-α,
are up-regulated by LPS (Shuster et al., 1993; Guha
and Mackman, 2001). The up-regulation of these cytok-
ines is mediated by the interaction of LPS with the
accessory proteins, LPS-binding protein (LBP), and
CD14 (Guha and Mackman, 2001). An acute phase pro-
tein binding with circulating LPS, LBP, facilitates the
transfer of LPS to membrane-associated CD14
(mCD14), which is found onPMNand cells of themono-
cytic lineage (Wright et al., 1990). The mCD14 is a
glycosyl phosphatidylinositol-anchored protein that
lacks an intracellular cytoplasmic domain, rendering it
incapable of signal transduction across the cell mem-
brane. In cells lacking mCD14, such as epithelial and
endothelial cells, activation is dependent on cellular
recognition of LPS-LBP complexes bound to circulating
soluble CD14 (sCD14), which is derived from the shed-
ding of mCD14 (Tapping and Tobias, 1997) from CD14-
bearing cells. Toll-like receptor (TLR)-4 has been iden-
tified in both cells of the monocytic lineage and non-
mCD14-bearing cells as a LPS transmembrane receptor
capable of activating cells (Chow et al., 1999; Faure et
al., 2000). Recently, it was shown that LBP, in addition
to transferring LPS to CD14, also forms an integral part
of a trimolecular LPS-LBP-sCD14 complex. Monocytes
can, therefore, detect the presence of LPS at concentra-
tions as low as 10 pg/mL (Thomas et al., 2002). Trans-
membrane signaling and cell activation in cells lacking
mCD14 are thought to be associated with TLR-4
through a cell surface assembly of a multiprotein recog-
nition complex consisting of CD14, MD-2, and TLR-4
(Akashi et al., 2000). Activation and transmembrane
signal transduction through the TLR-4 complex acti-
vates several NF-κB controlled genes such as IL-8 in
endothelial cells (Aderem and Ulevitch, 2000).
A role for sCD14 and LBP in mediating bovine host
responses to intramammary LPS or E. coli challenge
has recently been demonstrated (Wang et al., 2002;
Bannerman et al., 2003; Lee et al., 2003a, b). Following
intramammary LPS infusion, sCD14 increases in milk
(Bannerman et al., 2003; Lee et al., 2003a) paralleled by
an increase in LBP (Bannerman et al., 2003). Moreover,
sCD14 has been shown to sensitize themammary gland
to LPS (Wang et al., 2002) and to reduce the severity
of experimental E. coli mastitis in mice (Lee et al.,
2003c) and cows (Lee et al., 2003b). Interestingly, maxi-
mal levels of the chemoattractant IL-8 were observed
before increases in either milk LBP or sCD14. This
suggests that initial host cell activation can occur in
the presence of basal levels of sCD14 and LBP
(Bannerman et al., 2003). Furthermore, PMN influx,
as determined by SCC, were similarly elevated before
increases in sCD14 and LBP, indicating that height-
ened levels of these molecules were not required for
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immediate host innate immune responses (Bannerman
et al., 2003).
Several physiological factors impact the clinical out-
come of E. coli mastitis (Burvenich et al., 2003). Early
lactating cows, infected with E. coli, are more severely
affected than cows after peak lactation (Hill, 1981).
This is mainly due to the impairment of early lactation
leukocyte function, which begins a few weeks before
parturition and only recovers several weeks postpar-
tum (Kehrli et al., 1989; Sordillo and Babiuk, 1991a,
b; Sordillo and Peel, 1992; Detilleux et al., 1995;
Dosogne et al., 1999; Mehrzad et al., 2002). This pro-
nounced immunosuppresion is not only related to par-
turition itself (Kimura et al., 1999), but it is influenced
by several periparturient diseases (Kehrli and Goff,
1989) and has a consequence on many other diseases,
such as retained placenta (Kimura et al., 2002). In addi-
tion to stage of lactation, parity was also reported to
be an important physiological factor that influences se-
verity of clinical mastitis (Gilbert et al., 1993; van
Werven et al., 1997; Mehrzad et al., 2002; Vangroen-
weghe et al., 2004). Blood PMN function was higher in
younger animals than in cows after their fourth parturi-
tion (Gilbert et al., 1993; vanWerven et al., 1997).More-
over, PMN viability and oxidative burst activity have
been found to be significantly different between primip-
arous cows and multiparous cows during the peripart-
urient period (Mehrzad et al., 2002). In a nonrandom-
ized intramammary challenge study using large num-
bers of E. coli, primiparous cows reacted as moderate
responders based on their quarter milk production
(QMP) in the noninfected quarter on d +2 postinfection.
Based on clinical severity, all of the primiparous ani-
mals were scored as mild to moderate in their clinical
response throughout the entire experimental challenge
period (Vangroenweghe et al., 2004).
The purpose of the present study was to quantify
several inflammatory mediators and cytokines and to
evaluate the outcome of intramammary E. coli inocula-
tion in primiparous cows under identical conditions as
described previously (Vangroenweghe et al., 2004) with
a fully randomized study design, using 2 high inoculum
doses, with a 100-fold difference (1 × 104 and 1 × 106)
in colony-forming units. This difference in inoculum
dose was based on the amount of LPS produced related
to the number of E. coli bacteria injected (Burvenich,
1983; Monfardini et al., 1999). The hypothesis of the
present study is that the application of 2 different inocu-
lum doses elicits differences of the innate immune re-
sponse. An effect of 2 different inoculum doses in highly
resistant primiparous cows has never been studied be-
fore, and it is important to have a better insight into
the mechanism of innate immune response in these
animals.
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MATERIALS AND METHODS
Experimental Animals and Study Facilities
All primiparous cows (n = 16) calved within 3 d before
arrival at the dairy facility (Commercial Dairy Farm
Oudenaarde, Oudenaarde, Belgium). They were fed
twice daily at 0700 and 1700 h. The ration consisted of
corn silage, good quality hay, and water for ad libitum
intake. Concentrates (Sandilac; Dumoulin Voeders
Sanders, Moorslede, Belgium) were fed according to
milk production.
For inclusion into the trial, treatment of clinical di-
seases was not allowed within 10 d before intramam-
mary inoculation. Animals were free of major mastitis
pathogens through 3 consecutive bacteriological exami-
nations andwith a quarter foremilk SCC <200,000 cells/
mL. Primiparous cows accepted for the intramammary
challenge were inoculated between 14 and 28 d postpar-
turition.
Milking was performed daily at 0800 and 1800 h
using a quarter milking machine (Packo & Fullwood,
Zedelgem, Belgium). The QMP was measured at d −4,
−1, 0 (postinfusion hour [PIH] 0 to 24), 1 (PIH 24 to
48), 2 (PIH 48 to 72), and 3 (PIH 72 to 96).
Inoculation Dose
The generation time ofE. coli inmammary secretions
can be as short as 20 min (Burvenich et al., 2003).
Because we were interested in bacterial elimination
rather than in bacterial growth in experimentally in-
fected mammary glands, 2 high inoculum doses, 1 × 104
(Group A; n = 8) and 1 × 106 (Group B; n = 8) cfu,
were used.
Intramammary Inoculation Procedure
Inoculation was performed as previously described
(Vangroenweghe et al., 2004). Briefly, E. coli P4:O32
(Bramley, 1976) (H37, β-glucuronidase +, haemolysin
−), maintained in lyophilization medium at −20°C, was
subcultured in brain-heart infusion broth (CM225; Ox-
oid, Nepean, ON, Canada) at 37°C during 3 consecutive
d, subsequently washed 3× with pyrogen-free PBS, and
resuspended in PBS. Just before inoculation, the sus-
pension was diluted in pyrogen-free PBS to a final con-
centration of 1 × 104 cfu/mL (Group A) or 1 × 106 cfu/
mL (Group B). On d 0, 30 min after morning milking
(1.5 h after feeding), the cows were inoculated in the
left front and rear quarters with a total volume of 10
mL, consisting of 1mL of inoculumand9mLof pyrogen-
free saline solution (NaCl 0.9%; Baxter N.V., Lessines,
Belgium) per quarter.
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Animals were randomly assigned to one of both treat-
ment groups and challenged on 2 different trial d (8
cows per challenge day, 4 cows per treatment group).
Sampling Procedure
Blood and milk samples were collected at d −4, −1,
0, 1, 2, and 3 relative to the day of challenge. On the
day of challenge, blood and milk samples were collected
at PIH 3, 6, 9, 12, 15, 18, and 21.
Blood samples were drawn (10 mL) aseptically from
the external jugular vein of each cow by venipuncture
into evacuated tubes for preparation of plasma and se-
rum. Foremilk was aseptically collected for diagnostic
bacteriology, SCC, and preparation of skimmed milk.
All samples were maintained on ice up to the time of
processing.
Clinical Examination
Rectal temperature, heart rate, respiration rate, ru-
men motility, skin turgor, fecal appearance, appetite,
general attitude, BCS (Edmondson et al., 1989), and
aspects of the mammary gland (abnormal milk, swell-
ing, teat relaxation, and milk leakage) (Massart-Lee¨n
et al., 1988) were recorded by a veterinarian each time
blood and milk samples were collected.
Severity Determination
The severity of E. colimastitis was determined based
on QMP in the noninfected quarters at d 2 postinfusion.
Animals with a QMP in the noninfected quarters at d
+2 that was >50% compared with their QMP at d −1 in
the same quarters were scored as moderate responders,
whereas animals with a QMP at d +2 that was <50%
were considered severe responders (Vandeputte-Van
Messom et al., 1993; Dosogne et al., 1997, 1999; Van-
groenweghe et al., 2004). Clinical severity estimation
was scored as described byVangroenweghe et al. (2004).
Briefly, clinical data (rectal temperature, skin turgor,
reticulorumen motility, and general attitude) obtained
from PIH 9 to 48 were scored as described in Table 1,
and based on their total score, primiparous cows were
classified into mild, moderate, and severe responders.
SCC and Milk Composition
Somatic cell count was determined using a fluoro-
opto electronic method (Fossomatic 400 cell counter;
Foss Electrics, Hillerød, Denmark). Lactose concentra-
tion (g/L) was determined usingmidinfrared photospec-
trometry (Foss Electrics).
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Table 1. Severity estimation scheme, based on systemic disease signs for the classification of heifers,
following an experimental inoculation with Escherichia coli P4:O32 (Vangroenweghe et al., 2004). Briefly,
the 4 parameters are scored. Then, the total score is calculated and compared with respective ranges for
classification into mild, moderate, or severe disease.
Variable Criteria Score
Rectal temperature (°C) 37.80 to 39.25 0
39.30 to 39.80 1
>39.80 or <37.80 2
Skin turgor Regains normal shape in <5 s 0
>5 s to regain normal shape 1
Rumen motility rate (contractions/min) 3×/2 min 0
1 to 2×/2 min 1
0×/2 min 2
General attitude (signs of depression) Alert 0
Lethargic 1
Depressed—unable to stand 2
Extremely sick—recumbent 3
Total score Mild disease 0 to 2
Moderate disease 3 to 5
Severe disease 6 to 8
Indicators of the Breakdown
of the Blood-Milk Barrier
Milk samples for the determination of sodium, chlo-
rine, and potassium concentrations (mM/L) were centri-
fuged at 1000 × g (30 min, 4°C). Fat was removed,
and samples of skim milk were taken and immediately
frozen at −80°C until analysis. After thawing, ion con-
centration was analyzed using an ion-selective elec-
trode analyzer (Ilyte; Instrumentation Laboratories,
Milan, Italy).
Blood Leukocyte Count and Differentiation
Blood leukocyte count (BLC) (log10/mL) was deter-
mined using an electronic particle counter (Coulter
Counter Z2; Coulter Electronics Ltd., Luton, UK). Dif-
ferential BLC was performed on blood smears. Briefly,
10 µL of mixed whole blood were added onto a micro-
scope slide, and very thin smears were prepared. Fol-
lowing drying, smears were stained as described pre-
viously (Mehrzad et al., 2001). Differential counts of
the blood smears were carried out according to Wilde
(1964). Two hundred cells were counted on each smear,
and the percentage of PMN (mature, band cells and
myelocytes-metamyelocytes), monocytes, lymphocytes,
and eosinophils was determined. Myelocytes-metamye-
locytes were characterized by their round-oval to elon-
gated-arciform nuclei with yellowish cytoplasm. Band
cells had longer, circular formed nuclei with more con-
densed chromatin, situated near the periphery of the
cell. Mature PMN had clearly defined nuclei with 3 to
6 lobes and typical neutral granules. Monocytes were
round to irregular in shape containing greyish-blue cy-
toplasm, with foamy appearance in which fine red gran-
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ules can be found. The nuclear substance has a fine
reticulate structure with evenly distributed chromatin.
Lymphocytes had compact nuclei, surrounded by cyto-
plasm varying from a narrow band to a wider, more
irregular mass. Eosinophils had their specific eosino-
philic granules in the cytoplasm and nuclei with 2 to
3 lobes.
Colony-Forming Units in the Inoculated Quarters
The number of E. coli (cfu/mL) after experimental
inoculationwas determined by appropriate 10-fold dilu-
tions of each milk sample in PBS. Ten microliters of
these dilutions were plated out on Columbia Sheep
Blood agar (Biokar Diagnostics, Beauvois, France). All
dilutions were performed in duplicate. Colonies were
counted after a 24-h incubation at 37°C. The colony
count was converted to cfu/mL based on the factor of
dilution and finally expressed as log10/mL for statisti-
cal analysis.
ELISA for IL-8
Milk IL-8 levels were determined from undiluted
whey samples assayed with a commercially available
human IL-8 ELISA kit (R&D Systems, Inc., Minneapo-
lis, MN). The antibody pairs used in this kit have been
previously shown to cross-react with bovine IL-8 (Shus-
ter et al., 1996, 1997). The optical density at 450 nm
and a correction wavelength of 550 nm were measured
on an automated microplate reader (Bio-Kinetics
Reader; Bio-Tek Instruments, Winooski, VT). Values
expressed in picograms per milliliter were extrapolated
using linear regression from a standard curve of known
amounts of human IL-8.
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ELISA for Complement Fragment 5a
Using ELISA, the complement fragment 5a (C5a)
was quantified as previously described (Rainard et al.,
1998). Briefly, flat-bottomed microtiter plates (Immu-
lon 1; Dynatech, Chantilly, VA) were coated with 100
µL of goat antimouse IgG (Jackson Immunoresearch
Laboratories, West Grove, PA) diluted to 2 µg/mL in
0.1 M carbonate bicarbonate buffer (pH 9.6) for 1.5 h
at 39°C. After each incubation, the plates were washed
5× with PBS supplemented with 0.1% (vol/vol) Tween
20. Unsaturated binding sites were blocked with a solu-
tion of 0.5% (wt/vol) gelatin. The sequence of incubation
steps with 100-µL reagents diluted with PBS supple-
mented with 0.1% (vol/vol) Tween 20 plus 0.1% gelatin
was as follows: 1) a 1/10,000 dilution of the antiC5a
Mab 6G4 for 1 h; 2) 2-fold dilutions of purified C5adesArg
for the calibration curve, or appropriate dilutions of the
sample under test, diluted in PBS supplemented with
0.1% (vol/vol) Tween 20 plus 0.1% gelatin containing
1 mM EDTA for 1.5 h; 3) a 1/5000 dilution of rabbit
antibovine C5a/C5 for 30 min; 4) a 1/10,000 dilution of
goat antirabbit IgG (Jackson Immunoresearch Labora-
tories) for 30 min; 5) 52 mM 2,2′-azido-di-(3-ethylbenz-
thiazoline-6-sulfonic acid) (ABTS; Sigma) in 0.1 M ci-
trate buffer (pH 4.2) with 7.5 mM hydrogen peroxide
(Sigma). The absorbance at 415 nmwas read after about
30 min with an automated microplate reader (Bio-Ki-
netics Reader; Bio-Tek Instruments). Values expressed
in nanograms per milliliter were extrapolated using
linear regression from a standard curve of known
amounts of C5adesArg (Rainard et al., 1998).
ELISA for sCD14
A sandwich ELISAwas used to quantify sCD14 levels
inmilk as described byBannerman et al. (2003). Briefly,
flat-bottom 96-well plates were coated overnight with 5
µg/mL of mouse antibovine CD14 monoclonal antibody
(CAM36A; VMRD, Inc., Pullman, WA) diluted in 0.05
M sodium carbonate-bicarbonate (Sigma) (pH 9.6) at
4°C. The plates were washed 4× with 0.05% Tween 20
diluted in 50 mM Trizma-buffered saline (Sigma) (pH
8.0) and subsequently blocked with 2% fish skin gelatin
(Sigma Chemical Co.) for 1 h at room temperature.
Plates were washed, and 100 µL of diluted whey sam-
ples (1:10) were added to each well in duplicate. Plates
were incubated for 1 h at room temperature and subse-
quently washed as previously described. Mouse antibo-
vine CD14 antibody (MM61A; VMRD, Inc.) was conju-
gated to horseradish peroxidase using a commercially
available kit (EZ-Link Plus Activated Peroxidase Kit;
Pierce Chemical Co., Rockford, IL) and was used as
the detection antibody. This horseradish peroxidase-
conjugated antibovine CD14 antibody was diluted
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1:1000 in Trizma-buffered saline wash buffer con-
taining 2% gelatin, and 100 µL of the resulting solution
were added to eachwell. Plateswere incubated for 1 h at
room temperature and washed as previously described;
100 µL of 3,3′,5,5′-tetramethylbenzidine substrate solu-
tion (Pierce Chemical Co.) were added to each well. The
reaction was stopped by the addition of 100 µL of 2 M
H2SO4, and the absorbance was read at 450 nm on a
microplate reader (Multiskan PLUS; Labsystems, Hel-
sinki, Finland). A background correction reading of 550
nm was subtracted from the 450-nm absorbance read-
ings. Values expressed in micrograms per milliliter
were extrapolated using linear regression from a stan-
dard curve of known amounts of recombinant bovine
sCD14 (Wang et al., 2002).
ELISA for LBP
Milk and plasma LBP levels were determined with
a commercially available LBP ELISA kit that cross-
reacts with bovine LBP (Cell Sciences, Inc., Norwood,
MA). Milk and plasma samples were diluted 1:400 and
1:1500, respectively, and assayed according to theman-
ufacturer’s instructions. The optical density at 450 nm
and a correction wavelength of 550 nm were measured
on a microplate reader (Multiskan PLUS; Labsystems).
The concentration of LBP was calculated by extrapola-
tion using linear regression from a standard curve of
known amounts of human LBP.
Statistical Analysis
To compare the 2 inoculum groups with respect to
the various parameters analyzed in blood and milk, a
mixed model was used, with cow as random effect and
time, inoculum, and their interaction as categorical
fixed effects. Furthermore, for the SCC, colony-forming
units, rectal temperature, IL-8, C5a, sCD14, and LBP,
the 2 inoculum doses were compared at PIH 6, 9, and
12 using Bonferroni’s multiple comparisons procedure
with an overall type I error equal to 5%.
The significance between the number of animals in
the different categories of the clinical score was tested
using the Fisher Exact test.
RESULTS
QMP Decreases Temporarily Because
of the Intramammary E. coli Challenge
In the infected quarters, QMP decreased (P < 0.0001)
on d 0, the day of intramammary inoculation. Themaxi-
mal decrease of 60 to 70% appeared already on the day
of infection (Figure 1a). The QMP decrease (68%) was
slightly more pronounced in Group B, with a slightly
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Figure 1. Milk production of the infected left (a) and noninfected
right quarters (b) from d −1 until d +3 from primiparous cows infused
with 1 × 104 (—; Group A; n = 8) and 1 × 106 (- - -; Group B; n = 8)
cfu Escherichia coli P4:O32. Data are means (± SEM).
more rapid recovery on d +1, but no significant differ-
ences between the 2 doses were found. On d +3, the
recovery in the infected quarters was still incomplete
and averaged 86 and 76% of the preinfection QMP in
Groups A and B, respectively.
The QMP decrease in the contralateral noninfected
quarters is considered to be an indicator of general
systemic illness caused by IMI in the left quarters. A
moderate and short-termed decrease in the QMP of
the contralateral quarters was present in both infusion
groups (Figure 1b). Based on QMP at d +2, no severe
responders were observed in the 2 groups. At d +3,
relative to the day of infusion, QMP of these quarters
was at 97 and 99% of the preinfection QMP in Group
A and B, respectively.
Intramammary Challenge with E. coli Induces Both
a Local and Systemic Inflammatory Response
After the intramammary E. coli inoculation in both
infusion groups, rectal temperature rapidly increased
and was significantly higher (P < 0.002) at PIH 6 and
9 in Group B compared with Group A. The fever peak
appeared 3 h earlier and was highest in Group B, which
received the 1 × 106 cfu inoculum (Figure 2a). As indi-
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cated by the significant interaction between time and
inoculum (P < 0.0001), the kinetics of the rectal temper-
ature curve significantly differed between the infusion
groups. Heart rate and respiration rate followed identi-
cal kinetics as rectal temperature (results not shown).
Rumen motility was reduced in both infusion groups
from PIH 9 onward. However, the depression of
reticulorumen motility was less pronounced in Group
A, with only 3 animals showing a slight decrease in
motility (1 to 2×/2 min); one animal showed a complete
absence of reticulorumen activity at PIH 9. In Group
B, the depression of rumen motility was also maximal
at PIH 9: 3 animals with absence of motility and 4
animals showing a slight decrease in rumen motility.
Reticulorumen returned to normal motility by PIH 24
in both infusion groups (results not shown).
Local clinical signs at the level of the infected mam-
mary glands appeared early during inflammation. In
Group B, the first changes in milk appearance (color,
flakes, etc.) occurred at PIH 9, with a maximum around
PIH 15. Swelling of the infected quarters occurred at
PIH 6, with a maximum on PIH 9, at the time when
PMN influx in the glands became apparent through
increases in SCC. Pronounced swelling disappeared
gradually, and it was already at a low level (6 quarters
with moderate swelling) at PIH 72. In the group receiv-
ing the low inoculum dose, changes in milk appearance
and quarter swelling were equal to Group B, but the
onsetwas about 3 h later. Teat relaxation,milk leakage,
and diarrhea only appeared in a small number of ani-
mals in both infusion groups. The BCS decreased
slightly from 3.5 to 2.5 from arrival at the dairy facility
until the end of the intramammary E. coli challenge.
Intramammary E. coli Challenge Induces Mainly
Mild and Moderate Responses in Primiparous
Cows Based on a Clinical Severity Scoring
Based on the clinical severity scoring by
Vangroenweghe et al. (2004), clinical changes appeared
earlier in Group B compared with Group A. At PIH 9,
6 animals in Group B (n = 8) had a moderate clinical
score; however, inGroupA (n = 8), only 1 animal reacted
moderately, whereas the others still exhibited a mild
response (P = 0.041). By PIH 12, only 4 animals in
Group B (n = 8) reacted moderately, whereas in Group
A (n = 8), 6 animals showed a moderate response (P =
0.61) (Table 2). The clinical score normalized from PIH
15 onward, with only one animal in each group reacting
moderately at PIH 15 and none at PIH 18. No severe
responseswere observed in either of the infusion groups
at any time point between PIH 9 and 48.
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Figure 2. Rectal temperature (a), number of cfu Escherichia coli P4:O32 (b), lactose (c), milk sodium (d), milk potassium (e), and milk
chlorine (f) from postinfusion hour (PIH) 0 until PIH 48 in the infected quarters, respectively, from primiparous cows infused with 1 × 104
(—; Group A; n = 8) and 1 × 106 (- - -; Group B; n = 8) cfu E. coli P4:O32. Data are means (± SEM). PIH = postinfusion hour.
Intramammary Growth of the Inoculated E. coli
Resulted in a Pronounced Increase of SCC Through
Recruitment of Circulating Blood Leukocytes
The number of E. coli increased to peak values (3.96
and 3.20 log10 cfu/mL) at PIH 3 and 6 in the high and
low dose infusion groups, respectively. On average, the
number of E. coli did not significantly differ between
Table 2.Classification of heifers intomild, moderate, and severe responders based on the severity estimation
score at postinfusion hour (PIH) 9 and 12. The numbers mentioned in the body of the table represent the
number of animals with the specified score (sum of clinical parameters as specified in Table 1) at the
respective PIH. In the present study, the total score did not exceed 5, meaning that no severe responses
were observed throughout the entire experimental study period.
Clinical score
Mild response Moderate response Severe response
PIH Group 0 1 2 3 4 5 6 7 8
9 A 2 2 2 2 0 0 0 0 0
B 0 0 1 5 2 1 0 0 0
12 A 0 1 1 5 1 0 0 0 0
B 0 2 2 3 1 0 0 0 0
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the infusion groups. Furthermore, no significant inter-
action between time and inoculum dose were found,
indicating that the number of E. coli changed over time
in a similar fashion for the 2 inoculumdoses (Figure 2b).
The SCC rapidly increased following intramammary
E. coli infection and was significantly (P < 0.0001)
higher at PIH 6 in the high dose infusion group com-
pared with the group receiving the low dose. At PIH 9,
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Figure 3. Interleukin-8 (a), complement fragment 5a (C5a) (b), soluble CD14 (sCD14) (c), plasma LPS-binding protein (LBP) (d), milk
LBP (e), SCC (f), blood leukocyte count (g), percentage of myelocytes-metamyelocytes (h), percentage of band cells (i), and percentage of
mature polymorphonuclear neutrophil (PMN) (j) from postinfusion hour (PIH) 0 until PIH 48 in the infected quarters or blood, respectively,
from primiparous cows infused with 1 × 104 (—; Group A; n = 8) and 1 × 106 (- - -; Group B; n = 8) cfu Escherichia coli P4:O32. Data are
means (± SEM). PIH = postinfusion hour.
both infusion groups reached a plateau level of 106.57
cells/mL (Figure 3f). Peak SCC levels were reached at
PIH 15 and 18 in Groups B and A, respectively. The
SCC kinetics significantly differed (P = 0.0005) between
the inoculum groups, especially because of the earlier
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cellular influx (PIH 6) in the infected quarters in Group
B. At PIH 72, SCC did not yet attain preinfection
SCC levels.
Although BLC decreased after intramammary E. coli
infection, kinetics of the BLC decrease did not differ
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significantly between the inoculum groups. Nadir BLC
was reached at PIH 12 in both infusion groups, and
normal levels of circulating blood leukocytes appeared
at PIH 48 (Figure 3g).
Intramammary E. coli Challenge Induces
the Appearance of Immature PMN
into the Blood Circulation
Following intramammary challenge, marked
changes in differential BLC appeared, resulting in an
increased number of early (myelocytes-metamyelo-
cytes) and late (band cells) immature PMN in the blood
circulation. Band cells increased from PIH 3 to peak at
PIH 12 (Group B; 29.1 ± 6.4%) and PIH 15 (Group A;
27.2 ± 2.4%). A second peak was observed at PIH 21
(32.3 ± 2.8 and 31.6 ± 4.0% in Groups A and B, respec-
tively), after which the percentage of band cells de-
creased to normal levels by PIH 216 (Figure 3i). Early
immature cells (myelocytes-metamyelocytes) appeared
more frequently in the circulation from PIH 12 (Group
B) and PIH 15 (Group A) onward, with peak values at
PIH 18 (Group A; 24.1 ± 2.5%) and PIH 21 (Group
B; 18.8 ± 1.1%). Myelocytes-metamyelocytes gradually
decreased in the following 96 h to reach normal levels
at PIH 144 to 216 (Figure 3h).
Mature PMN migrated from the circulation into the
infected quarters, which resulted in a decreased per-
centage from PIH 9 onward in both groups, with nadir
at PIH 15 (1.0 ± 0.6 and 3.5 ± 2.0% in Groups A and
B, respectively). The percentage of circulating mature
PMN gradually recovered and reached preinfection val-
ues by PIH 144 (Figure 3j).
Intramammary E. coli Challenge Induces Disruption
of the Blood-Milk Barrier and Stimulates IL-8
and C5a Production in the Mammary Gland
Lactose, sodium, potassium, and chloride are good
indicators to assess the damage of the blood-milk bar-
rier caused by the present IMI. Lactose decreased sig-
nificantly in Group B from PIH 6 onward, to nadir at
PIH 12 in both groups. In Group A, the disruption of
the blood-milk barrier appears 3 h later, with a decrease
in lactose content at PIH 9 (Figure 2c). Similarly, so-
dium and chloride concentrations in Group B increased
from PIH 6 to peak a first time at PIH 9. Following a
slight decrease at PIH 15, a second peak was reached
at PIH 18. In Group A, infused with 1 × 104 cfu per
quarter, the onset of increased concentrations of sodium
and chloride appeared at PIH 9, with maximal concen-
trations at PIH 18 (Figure 2, d and f). In contrast with
the observed changes in sodium and chloride concentra-
tions, potassium kinetics did not significantly differ be-
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tween both infusion groups. Nadir was reached at PIH
12, followed by a slow restoration of initial potassium
levels by PIH 48 (Figure 2e).
Before challenge, IL-8 was hardly detectable (2.19 ±
0.93 and 1.89 ± 0.84 pg/mL in Groups A and B, respec-
tively) in the quarters that were to be infused with E.
coli. The IL-8 kinetics of the 2 infusion groups differed
significantly from each other. In Group B, a significant
increase in IL-8 appeared as early as PIH 6 and reached
a peak of 305 ± 36 pg/mL at PIH 12 (Figure 3a). At
PIH 6 and 9, the concentration of IL-8 in the inflamed
quarters was significantly higher (P < 0.05) in Group B,
which received the 1 × 106 cfu inoculum dose. Following
infusion of 1 × 104 cfu (Group A), significant increases
in IL-8 occurred at PIH 9 and reached peak levels of
240 ± 40 pg/mL at PIH 12. Elevated levels of IL-8 per-
sisted until PIH 24 in both groups, after which the
levels returned to baseline.
The complement component C5a had similar kinetics
in both groups. The initial increase in C5a following
intramammary challenge appeared at PIH 6 (±1.5 ng/
mL), and it rapidly increased to 37.1 ± 16.0 ng/mL and
30.6 ± 12.4 ng/mL at PIH 12 for Groups A and B, respec-
tively. Elevated levels of C5a persisted until PIH 24 in
both groups, after which the levels returned to baseline
(Figure 3b).
Intramammary E. coli Challenge Increases
Milk sCD14 Levels
To determine whether E. coli could alter mammary
gland levels of sCD14, a sandwich ELISA was used to
quantitate milk sCD14 (Figure 3c). Before challenge,
sCD14 in mammary quarters (7.7 ± 2.7 and 10.4 ± 3.1
µg/mL for Groups A and B, respectively) was in the
range previously described (Lee et al., 2003a) for early
lactating noninfected glands (5.46 to 6.90 µg/mL). At
PIH 6, a significant increase in milk sCD14 was ob-
served in Group B, whereas in Group A, the increase
in milk sCD14 only appeared at PIH 9. Concentrations
of sCD14 were significantly (P < 0.0001) different be-
tween the 2 groups at PIH 12. Milk sCD14 peaked at
PIH 15 in both groups, although the level of sCD14 was
significantly higher (P = 0.0323) (205 ± 44 µg/mL) in
Group B compared with Group A (151 ± 54 µg/mL)
(Figure 3c).
Increased Levels of LBP in Milk Following
Intramammary Challenge with E. coli
It has been shown previously (Bannerman et al.,
2003) that elevated levels of sCD14 are associated with
similar increases in milk LBP, thereby providing an
environment for optimal host recognition of LPS, origi-
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nating from infused E. coli bacteria. Plasma LBP was
also assayed, as it is known that hepatic synthesis of
this protein increases during the acute phase response,
mainly because of hepatic cell stimulation by IL-1β and
IL-6 (Tobias et al., 1999). Under basal conditions, LBP
was detected in bovine blood at concentrations of 29.8
± 7.5 and 41.9 ± 5.4 µg/mL for Groups A and B, respec-
tively; whereas the concentration of LBP in milk was
lower with 8.5 ± 5.1 and 14.5 ± 11.5 µg/mL for Groups
A and B, respectively. At PIH 9, plasma LBP in Group
B increased, and this increase persisted throughout the
entire study period (Figure 3d). Plasma LBP levels
reached maximal levels of 70.1 ± 1.5 and 68.8 ± 1.1 µg/
mL at PIH 18, after which they slightly declined to
reach a plateau until the end of the study. In quarters
inoculated with E. coli, significant elevation of milk
LBP was observed as early as PIH 9, resulting in a first
peak at PIH 15 (44.4 ± 10.6 and 40.4 ± 8.7 µg/mL in
Groups A and B, respectively). Milk LPB was signifi-
cantly (P = 0.0431) higher in Group B at PIH 12. A
second peak (61.6 ± 12.3 and 61.2 ± 12.0 µg/mL in
Groups A and B, respectively) was reached at PIH 24,
after which milk LBP levels remained high until the
end of the study (Figure 3e). Peak levels of milk LBP
were observed 6 h later than the maximal elevation of
plasma LBP levels.
DISCUSSION
In this study, the same strain and range of high inocu-
lum doses of E. coli was used to induce E. coli mastitis
as reported in previous studies (Heyneman et al., 1990;
Vandeputte-Van Messom et al., 1993; Hoeben et al.,
2000; Dosogne et al., 2002; Vangroenweghe et al., 2004).
The outcome of experimental E. coli inoculation was
expected based on the results obtained in a previous
study with primiparous cows under identical conditions
(Vangroenweghe et al., 2004). In the present study,
none of the animals reacted severely following intra-
mammary E. coli challenge. Animals were scored as
described by Vangroenweghe et al. (2004), which re-
sulted in a similar classification of mild and moderate
responses. Interestingly, the time of latency to become
moderately ill was approximately 3 h shorter in Group
B compared with Group A.
The number of circulating PMN, a marker to predict
the clinical outcome of the disease, was similar to the
levels previously observed in moderate responders
(Vandeputte-Van Messom et al., 1993; Vangroenweghe
et al., 2004). Primiparous cows in this study could,
therefore, be expected to react with a moderate clinical
response. Following intramammary E. coli challenge, a
rapid decrease of circulating PMNwas observed, which
coincided with the influx of PMN into the infected quar-
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ters and started around PIH 6 to 9. Remarkably, no
significant difference in BLC kinetics could be observed
between the infusion groups, whereas, for SCC, a sig-
nificantly earlier influx was observed in the high dose
inoculum group.
The onset of local clinical signs of mastitis, character-
ized by quarter swelling, coincided with the influx of
PMN to the infected quarters. The SCC increased
rapidly in both groups, which is in accordance with
earlier observations, where moderate responders had
a rapidly occurring leukocytosis in the infected glands
(Vandeputte-VanMessom et al., 1993). However, in the
present study, distinct differences in the onset of PMN
influx into the infected glands could be observed. The
extraction ofmature PMN from the blood to the infected
glands is known to result in early and late immature
PMN recruitment from the bone marrow to restore the
number of circulating PMN. Recently, IL-8 has been
shown to be responsible for rapid granulocytosis with
the release of PMN from the bone marrow (Terashima
et al., 1998). In the present study, IL-8 was released
from PIH 6 to 9, which coincided with the appearance
of significantly increased numbers of band cells in the
blood circulation. However, the recruitment of PMN
was of short duration, compared with Heyneman et al.
(1990), who observed immature forms in circulation for
at least 3 d in moderate responders and for almost 10
d in severe responders.
The rapid influx of PMN into the infected glands was
associated with rapid elimination of bacteria from the
quarters. In contrast to an earlier study with the same
inoculum dose in multiparous animals (Vandeputte-
VanMessom et al., 1993), peak bacterial numbers were
already reached around PIH 3 to 6, which was in accor-
dance with a previous study in primiparous cows
(Vangroenweghe et al., 2004). Contrary to the induction
ofE. colimastitis with low inoculumdoses, where elimi-
nation is preceeded by excessive bacterial growth (Shus-
ter et al., 1996, 1997; Riollet et al., 2000; Scaletti et al.,
2003), in this study, peak numbers were reached within
6 h postinfusion and followed by a subsequent bacte-
rial elimination.
Several indicators (lactose, sodium, chloride, and pot-
assium) for the disintegration of the blood-milk barrier
were determined in this study. The changes appeared
significantly earlier (approximately 3 h) in Group B,
receiving the 1 × 106-cfu inoculum dose, although peak
levels were almost identical for both groups, which coin-
cides with all other data, indicating that the animals
reacted with a mild to moderate response and little
variation in clinical response was present in this study.
Complement component C5a and its derivative
C5adesArg play a potential role in the inflammatory re-
sponse accompanying mastitis (Rainard et al., 1998).
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The level of C5a/C5adesArg on the day of challenge was
within the range previously described by Rainard et
al. (1998), taking into account that the average SCC
immediately before intramammary infusion was a little
higher (approximately 90,000 vs. 25,000 cells/mL). In
the present study, increased levels of C5a/C5adesArg
could be observed from PIH 3 onward, which is in accor-
dance with an earlier study (Rainard et al., 1998), al-
though in that study the induction of inflammatory
symptoms was performed with E. coli endotoxin and
not with live bacteria. The assessment of C5adesArg con-
centrations in milk following infusion of E. coli endo-
toxin or live bacteria showed that biologically signifi-
cant amounts of C5a/C5adesArg are present in mastitic
milk. The bulk of complement-derived components in
mastitic milk are likely to have their origin in blood
plasma, exudating through the damaged blood-milk
barrier following inflammation of the mammary gland
(Rainard et al., 1998). However, milk concentrations of
C5a/C5adesArg are probably not a reliable indicator of
exudation, as C5a/C5adesArg is rapidly taken up by sev-
eral cell types present in inflamed milk, in particular
PMN (Rainard et al., 1998). Major clearance mecha-
nism of this inflammatory mediator is believed to rely
on the binding of C5a/C5adesArg to cell surface receptors.
As milk from inflamed quarters contained high concen-
trations of cells, mainly PMN, it can be put forward
that the concentrations of C5a/C5adesArg measured in
milk were underestimates of the total amounts of C5a/
C5adesArg originally generated. Complement fragment
5a generated inmilk could well contribute to the activa-
tion of the recruited phagocytic cells, with the conse-
quence of improving their bactericidal activity
(Rainard, 2003).
Interleukin-8 is considered to play an important role
in PMN recruitment to the inflamed quarters
(Baggniolini and Clark-Lewis, 1992; Barber and Yang,
1998). In contrast to Shuster et al. (1997), who sug-
gested the importance of C5a is greater than IL-8 dur-
ing the early inflammatory response mainly because of
earlier peak maxima, in the present study, peak levels
of IL-8 appeared 6 h earlier than C5a. The increase of
IL-8 chemotactic activity appears coincident with the
increment in SCC at the level of the infected quarters.
An increase in C5a also appeared as early as PIH 3 to
6, but its peak maximum was only reached at PIH 18.
The induction of IL-8 production and release is known
to be independent of the presence of IL-1β and TNF-α
(Persson-Waller et al., 2003).
Detectable increases inmilk LBPwere observed after
initial increases in blood LBP, and maximal levels of
LBP in milk were observed at PIH 24, some 6 h after
the peak levels of plasma LBP. In accordance with
Bannerman et al. (2003), the increases in milk LBP
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paralleled increments in sCD14 levels. From a host
perspective, the simultaneous increase in both LBP and
sCD14 levels would be expected to be advantageous as
both molecules act in concert to facilitate activation of
host defense mechanisms by presenting LPS, released
during bacterial growth and death, to the transmem-
brane LPS receptor, TLR-4 (Bannerman andGoldblum,
2003). Although the increase in sCD14 was earlier and
significantly higher in Group B, PMN influx as deter-
mined by SCC in the infected quarters was similarly
elevated before pronounced increment of sCD14. It was
proposed that heightened levels of these molecules are
not required for immediate host innate immune re-
sponses (Bannerman et al., 2003). However, peak levels
of SCC were not observed until PIH 15 to 18, at a
time where levels of both sCD14 and LBP in milk were
elevated. Whether increments in sCD14 and LBP are
necessary for maximal recruitment of PMN to the in-
flamed mammary glands remains unknown.
From this study, it appears that the inflammatory
response in primiparous cows from Group B has an
earlier onset compared with Group A. One possible ex-
planation for this observation could be the 100-fold dif-
ference in the number of E. coli infused into the mam-
mary glands because the amount of LPS produced is
related to the number of E. coli bacteria (Burvenich,
1983; Monfardini et al., 1999). Because the bacterial
cultures were washed 3× in pyrogen-free PBS before
further dilutions were made, a direct effect of LPS pres-
ent in the inoculum can be excluded. Known as a potent
inducer of inflammatory cytokines (Shuster et al.,
1993), LPS can be produced quite rapidly during bacte-
rial growth following intramammary infusion. The in-
fused bacteria rapidly activated the complement system
through the alternative pathway, resulting in an early
abundant production of C5a. These effects resulted in
a rapid attraction of PMN from the blood into the mam-
mary gland, with a subsequent pronounced increase of
SCC in the infected glands.
The novelty of the present study is the fact that pri-
miparous cows, recently shown to react as mild to mod-
erate responders (Vangroenweghe et al., 2004), are re-
sponding faster following a 100-fold increase in the inoc-
ulumdose. This quicker response is related to an earlier
activation of innate host immunity.
Following E. colimastitis, treatment with antibiotics
at PIH 10 did not alter local and systemic symptoms
despite a 100-fold decrease in colony-forming units
(Monfardini et al., 1999). From the present study, it is
evident that at the set time point, antibiotic treatment
is unable to alter the production or release of various
inflammatory mediators. Therefore, it can be suggested
that early inflammatory events (first 3 h) could play a
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major role in the further regulation of the inflammatory
response to combat the invading pathogens.
CONCLUSIONS
Despite the use of relatively high inoculum doses,
primiparous cows react with a moderate inflammatory
response following intramammaryE. coli infusion. This
moderate response was evident from the preinfection
number of circulating leukocytes, the prompt clinical
response, the rapid influx of PMN into the infected
quarters, the efficient bacterial clearance of the affected
glands, and the fast recovery of QMP in both infected
and noninfected glands. In the present study, the differ-
ence in time of latency between both inoculum doses
could be confirmed and documented with kinetics of
various inflammatory mediators, such as sCD14, LBP,
IL-8, and C5a. The early increase in IL-8 following acti-
vation of the mammary gland epithelium appeared be-
fore increases in sCD14 or LBP, indicating that innate
host cell activation can occur in the presence of basal
levels of sCD14 and LBP. Although C5a increased dur-
ing early innate host immune response, maximal levels
were reached after IL-8 had peaked. In conclusion, heif-
ers were able to efficiently clear an intramammary E.
coli infection, and the increase in inoculum dose in-
duced a more rapid clinical response, mainly because
of the earlier activation of the innate host immune re-
sponse. To further elucidate the regulation of early
events, mammary gland biopsies and milk sample col-
lection during the early phase of inflammation should
be performed.
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